Sign in
Taking people in United StatesPhase 2/3

Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms

Key facts

Who runs it
Virginia Commonwealth University
Where
Richmond, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 2/3
People taking part
148 people, planned
Started
2 Sept 2025
Expected to end
Sept 2028
Type of study
Interventional, 2 groups
Treatments tested
  • HRV Coherence Ratio
  • NSI
  • Pittsburgh Sleep Quality Index (PSQI)
  • Quantitative Sleep Measures
  • Patient Global Impression of Change (PGIC)
  • Cognitive Performance/NIH Toolbox Cognitive Battery
  • Pain Interference/TBI-QoL Pain Interference Short-Form
  • Patient Health Questionnaire-9 (PHQ-9)
  • PTSD Checklist for DSM-5 (PCL-5)
  • HRV Biofeedback (HRV-B)
  • Psychoeducational (Edu) Comparator Intervention
Record updated
22 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • age 18 or older
  • History of military service
  • Self-Reported hx of 1 or more mild TBI
  • Most recent TBI more than 1 year ago
  • Significant Persistent Post-Concussion Symptom burden (Neurobehavioral Symptom Inventory [NSI] total score greater than or equal to 20)
  • Current Sleep Difficulties
  • Fluent English
  • Able to provide Informed Consent

Who cannot take part

  • Any TBI with severity greater than mild (i.e., Moderate or Severe TBI defined as initial injury loss of consciousness (LOC) duration >30 minutes, posttraumatic amnesia (PTA) duration >24 hours, or traumatic hemorrhage on head computerized tomography (CT) and determined by the study investigator based on information gathered during administration of the study's validated TBI structured interview instrument
  • Conditions or medications that can affect HRV measurement (pacemaker or an implant that stimulates your heart (e.g., cardioverter-defibrillator or ICD); heart transplant or heart surgery within the last year, including bypass or other surgery, but not including a stent)
  • Hx of stroke
  • Mental conditions that may impede adherence (e.g., dementia, psychotic disorder, panic disorder)

Where in United States

  • Virginia Commonwealth UniversityRichmond, United StatesContact: Bret BrooksTaking people

About the trial

What the trial wants to find out

Many combat veterans (c-Vs), service members (SMs) and civilians with mild traumatic brain injury (mTBI, also termed concussion) suffer from persistent post-concussion symptoms (PPCS) that degrade physical and cognitive well-being and have been linked with early neurodegeneration. PPCS include somatosensory (e.g., headache, disturbed vision), vestibular (e.g., dizzy, clumsy), cognitive (e.g., executive function, memory) and affective symptoms (e.g., sleep disturbance, irritability, depression). A key pathological process that provokes and perpetuates PPCS is autonomic nervous system (ANS) dysfunction such as unremitting sympathetic nervous system activation that also exacerbates other pathology such as inflammation. ANS activity can be readily quantified by measuring heart rate variability (HRV), or the variation in heart rate over time, which serves as a valid index of both physiological and psychological health

The 2 groups in the trial

  • Heart rate variability biofeedback (HRV-B)Treatment being tested

    Behavioral intervention using HRV biofeedback (HRV-B) to treat Persistent Post-Concussion Symptoms (PPCS) among adults, including Combat Veterans (c-Vs) and Service Members (SMs), with history of single or repeated mTBI from blast-related or other mechanism.

    Treatment: HRV Coherence Ratio, NSI, Pittsburgh Sleep Quality Index (PSQI), Quantitative Sleep Measures, Patient Global Impression of Change (PGIC), Cognitive Performance/NIH Toolbox Cognitive Battery, Pain Interference/TBI-QoL Pain Interference Short-Form, Patient Health Questionnaire-9 (PHQ-9), PTSD Checklist for DSM-5 (PCL-5), and HRV Biofeedback (HRV-B)

  • EducationTreatment being tested

    Psychoeducational treatment

    Treatment: HRV Coherence Ratio, NSI, Pittsburgh Sleep Quality Index (PSQI), Quantitative Sleep Measures, Patient Global Impression of Change (PGIC), Cognitive Performance/NIH Toolbox Cognitive Battery, Pain Interference/TBI-QoL Pain Interference Short-Form, Patient Health Questionnaire-9 (PHQ-9), PTSD Checklist for DSM-5 (PCL-5), and Psychoeducational (Edu) Comparator Intervention

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
22 September 2026